Trastuzumab: beside supportive care

46 studies: a supportive treatment or test is studied. Page 1 of 1. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Optimization of Cardiac Imaging in Women With Early-Stage Breast CancerRecruitingNCT07630402Not applicableReport a problem
• Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular ImagingNot yet recruitingNCT07527806Phase 2Report a problem
• Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant TreatmentNot yet recruitingNCT07508956Phase 3Report a problem
• Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or TrastuzumabRecruitingNCT07426913Not applicableReport a problem
• Grape Polyphenols for Prevention of Chemotherapy-Induced CardiotoxicityNot yet recruitingNCT07419711Not applicableReport a problem
• Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)Not yet recruitingNCT07257380Phase 2Report a problem
• Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer PatientsRecruitingNCT07233499Phase 2Report a problem
• JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First YearRecruitingNCT06930521Not applicableReport a problem
• Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or TrastuzumabNot yet recruitingNCT06881940Not applicableReport a problem
• Aromatherapy in the Treatment of Early Breast CancerNot yet recruitingNCT06435104Phase 2Report a problem
• A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast CancerNot yet recruitingNCT06362096Phase 2Report a problem
• Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced CardiotoxicityRecruitingNCT06341842Phase 2Report a problem
• NT-proBNP to Assess Trastuzumab-induced CardiotoxicityRecruitingNCT06340516Not applicableReport a problem
• The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac ToxicityRecruitingNCT06214195Phase 3Report a problem
• Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)RecruitingNCT05733689Phase 1Report a problem
• Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)RecruitingNCT05465031Phase 4Report a problem
• Correlation of Clinical Response to Pathologic Response in Patients With Early Breast CancerRecruitingNCT05020860Phase 2Report a problem
• Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or TrastuzumabCompletedNCT04023110Phase 1Results postedReport a problem
• Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and NeratinibCompletedNCT03094052Phase 2Results postedReport a problem
• Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer PatientsCompletedNCT02910219Phase 2Results postedReport a problem
• An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast CancerCompletedNCT02696707Phase 4Results postedReport a problem
• Fasting on Newly Diagnosed Breast CancerTerminatedNCT02379585Phase 1/2Results postedReport a problem
• Cardiac Safety Study in Patients With HER2 + Breast CancerCompletedNCT01904903Phase 2Results postedReport a problem
• Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabCompletedNCT01009918Phase 2Results postedReport a problem
• Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by MetoprololTerminatedNCT00806390Phase 4Results postedReport a problem
• Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell FunctionTerminatedNCT00169104Phase 2/3Results postedReport a problem
• Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant ChemotherpyActive, not recruitingNCT06190600Not applicableReport a problem
• Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer PatientsCompletedNCT05338723Phase 3Report a problem
• Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast CancerStatus unknownNCT04429633Not applicableReport a problem
• Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced CardiotoxicityCompletedNCT03964142Not applicableReport a problem
• Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart FailureTerminatedNCT03879629Phase 2Report a problem
• Prevention of Cardiac Dysfunction During Breast Cancer TherapyCompletedNCT03760588Phase 2Report a problem
• Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedNCT03432741Phase 1Report a problem
• Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related CardiotoxicityTerminatedNCT03089502Not applicableReport a problem
• A Prospective Study of Breast Cancer Patients With Abnormal Strain ImagingStatus unknownNCT02993198Phase 2Report a problem
• Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice NurseStatus unknownNCT02686918Not applicableReport a problem
• Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.CompletedNCT02632435Not applicableReport a problem
• High-Intensity Interval Training for Stage I-III Breast Cancer PatientsTerminatedNCT02454777Not applicableReport a problem
• Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast CancerTerminatedNCT02433067Not applicableReport a problem
• Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or TrastuzumabStatus unknownNCT02236806Phase 3Report a problem
• Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)TerminatedNCT01690325Phase 2Report a problem
• MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project ICompletedNCT01501487Phase 4Report a problem
• Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer TherapyCompletedNCT01434134Phase 2Report a problem
• Multidisciplinary Approach to Novel Therapies in Cardiology Oncology ResearchStatus unknownNCT01016886Phase 1/2Report a problem
• Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated CardiotoxicityCompletedNCT00459771Phase 3Report a problem
• Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast CancerStatus unknownNCT00398437Not applicableReport a problem

← Trastuzumab